Separation Agreements in the Health Care Equipment & Supplies Industry
342 Contracts & Agreements
- Abbott Laboratories (1 contract)
- ABIOMED Inc (1)
- Accelerate Diagnostics, Inc (2)
- ACCURAY INC (10)
- Acutus Medical, Inc. (1)
- AdvanSource Biomaterials Corp (1)
- AETHLON MEDICAL INC (2)
- AIRXPANDERS INC (1)
- Align Technology (4)
- ALLOS THERAPEUTICS INC (3)
- Alphatec Holdings, Inc. (2)
- Angiodynamics Inc (3)
- Apollo Endosurgery, Inc. (5)
- APPYEA, INC (1)
- Apyx Medical Corp (3)
- AquaMed Technologies, Inc. (1)
- Arch Therapeutics, Inc. (1)
- Arno Therapeutics, Inc (1)
- Audentes Therapeutics, Inc. (2)
- Avanos Medical Inc (1)
- Avinger Inc (2)
- AxoGen, Inc. (2)
- BARRIER THERAPEUTICS INC (2)
- Bausch & Lomb Corp (6)
- Baxter International Inc. (2)
- Bellerophon Therapeutics, Inc. (4)
- BIOLASE, INC (6)
- BIOMIMETIC THERAPEUTICS, INC. (1)
- Bionik Laboratories Corp. (3)
- Bioventus Inc. (1)
- Bluejay Diagnostics, Inc. (2)
- Boston Scientific (2)
- Cantel Medical Corporation (1)
- Cardiovascular Systems Inc (6)
- Carmot Therapeutics Inc. (1)
- Cascadian Therapeutics, Inc. (1)
- CHEMBIO DIAGNOSTICS, INC. (1)
- CHF Solutions, Inc. (5)
- Colfax CORP (1)
- CORNERSTONE THERAPEUTICS INC (2)
- CryoLife, Inc. (4)
- Cryoport, Inc. (1)
- Cutera, Inc. (2)
- Cytosorbents Corp (1)
- Danaher Corp. (1)
- Dare Bioscience, Inc. (4)
- DarioHealth Corp. (1)
- DELCATH SYSTEMS, INC. (1)
- Dentsply Sirona (3)
- DYNATRONICS CORP (4)
- Eargo, Inc. (1)
- Echo Therapeutics, Inc. (1)
- EKSO BIONICS HOLDINGS, INC. (1)
- Electromed, Inc. (2)
- Embecta Corp. (1)
- ENDOLOGIX INC (1)
- Envista Holdings Corp (4)
- ERBA Diagnostics, Inc. (1)
- ESTABLISHMENT LABS HOLDINGS INC. (1)
- GenMark Diagnostics, Inc. (5)
- GI DYNAMICS, INC. (1)
- Haemonetics (1)
- HealthCor Catalio Acquisition Corp. (2)
- HELIUS MEDICAL TECHNOLOGIES, INC. (3)
- Heska Corporation (7)
- Hill-Rom Holdings Inc. (6)
- Hologic (8)
- ICU Medical (1)
- IDEXX Laboratories (1)
- IMARX THERAPEUTICS INC (2)
- Inogen, Inc. (1)
- InspireMD, Inc. (2)
- Insys Therapeutics, Inc. (1)
- Integer Holdings Corporation (6)
- Integra Lifesciences Holdings (3)
- INTRICON CORP (1)
- Invacare Corporation (4)
- Invea Therapeutics, Inc (1)
- IRADIMED CORP (3)
- iRhythm Technologies, Inc. (1)
- IRIDEX CORP (2)
- KEWAUNEE SCIENTIFIC CORP (3)
- Kyverna Therapeutics, Inc. (1)
- Lantheus Holdings, Inc. (2)
- LENSAR, Inc. (1)
- LivaNova (4)
- Longview Acquisition Corp. (3)
- Lucira Health, Inc. (1)
- MELINTA THERAPEUTICS, INC. (3)
- Meridian Bioscience, Inc. (4)
- Merit Medical Systems, Inc. (6)
- MINERVA SURGICAL INC (1)
- MRI INTERVENTIONS, INC. (2)
- MYOMO INC (2)
- NanoVibronix, Inc. (1)
- Natus Medical Incorporated (1)
- Neogen Corporation (2)
- Neumora Therapeutics, Inc. (1)
- NeuroMetrix, Inc. (1)
- NeuroPace Inc (1)
- NEVRO CORP (5)
- NON INVASIVE MONITORING SYSTEMS INC (1)
- NOVELION THERAPEUTICS INC. (3)
- NuVasive Inc (6)
- Ocata Therapeutics, Inc. (1)
- Orexigen Therapeutics, Inc. (2)
- OSIRIS THERAPEUTICS, INC. (3)
- Oxford Immunotec Global PLC (1)
- OZOP SURGICAL CORP. (1)
- PAVmed Inc. (1)
- Precision Therapeutics Inc. (4)
- Presbia PLC (1)
- PRO DEX INC (4)
- Pulse Biosciences, Inc. (1)
- Q Therapeutics, Inc. (1)
- Quotient Ltd (3)
- ReShape Lifesciences Inc. (1)
- Restoration Robotics, Inc. (5)
- ReWalk Robotics Ltd. (1)
- RTI Surgical Holdings, Inc. (2)
- RTI SURGICAL, INC. (3)
- Sandbridge Acquisition Corp (1)
- SANUWAVE Health, Inc. (3)
- SeaSpine Holdings Corp (1)
- SECOND SIGHT MEDICAL PRODUCTS INC (2)
- Semler Scientific, Inc. (1)
- ShockWave Medical, Inc. (6)
- Sientra, Inc. (3)
- Sintx Technologies, Inc. (1)
- STAAR SURGICAL CO (1)
- STEMLINE THERAPEUTICS INC (1)
- STRATA Skin Sciences, Inc. (2)
- Stryker Corp. (2)
- TANDEM DIABETES CARE INC (1)
- Teleflex Inc (1)
- The Cooper Companies (2)
- TRANSENTERIX INC. (1)
- VAPOTHERM INC (3)
- Varex Imaging Corporation (1)
- Varian Medical Systems (2)
- VERMILLION, INC. (4)
- ViewRay, Inc. (9)
- VIVEVE MEDICAL, INC. (1)
- West Pharmaceutical Services (1)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (2)
- Xtant Medical Holdings, Inc. (1)
- Zimmer Biomet Holdings (2)
- ZimVie Inc. (1)
- Zosano Pharma Corp (1)
- ZYNEX INC (1)
- Separation and General Release Agreement, dated September 13, 2024, between Kyverna Therapeutics, Inc. and Peter Maag, Ph.D (Kyverna Therapeutics, Inc., Filed With SEC on September 16, 2024)
- Separation Agreement and General Release, dated as of May 29, 2024, by and between Sanara MedTech Inc. and Zachary B. Fleming (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on August 12, 2024)
- Separation and Release of Claims Agreement (Sintx Technologies, Inc., Filed With SEC on April 30, 2024)
- Separation and Release Agreement, dated March 29, 2024 (SANUWAVE Health, Inc., Filed With SEC on April 1, 2024)
- Separation Agreement and Mutual Release dated effective September 30, 2023, by and between the Company and Bob Myers (Precision Therapeutics Inc., Filed With SEC on March 28, 2024)
- Transition and Separation Agreement, dated February 7, 2024, by and between the Company and Irina Ridley (NeuroPace Inc, Filed With SEC on March 5, 2024)
- Transition and Separation Agreement, dated as of November 6, 2023, between Joseph F. Gordon and Bausch + Lomb Corporation (Bausch & Lomb Corp, Filed With SEC on February 21, 2024)
- Separation and Release Agreement, dated November 17, 2023, between Integer Holdings Corporation and Jennifer M. Bolt (Integer Holdings Corporation, Filed With SEC on February 20, 2024)
- Separation and Release Agreement, dated May 18, 2023, between Integer Holdings Corporation and Jason Garland (Integer Holdings Corporation, Filed With SEC on February 20, 2024)
- Separation Agreement and General Release between DH Dental Employment Services LLC and Patrik Eriksson, dated January 4, 2024 (Envista Holdings Corp, Filed With SEC on February 15, 2024)
- Separation Agreement between the Company and Dr. Fisher, effective as of November 27, 2023 (AETHLON MEDICAL INC, Filed With SEC on November 27, 2023)
- Separation Agreement and Release by and between the Company and Nabil Shabshab, dated November 22, 2023 (Inogen, Inc., Filed With SEC on November 27, 2023)
- Separation Agreement and Release, by and between the Registrant and Stig Hansen, dated January 31, 2023 (Carmot Therapeutics Inc., Filed With SEC on November 17, 2023)
- Separation Agreement, dated as of August 3, 2023, by and between Bellerophon Therapeutics, Inc. and Parag Shah (Bellerophon Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Separation Agreement, dated as of August 3, 2023, by and between Bellerophon Therapeutics, Inc. and Peter Fernandes (Bellerophon Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Separation Agreement, dated as of July 13, 2023, by and between Bellerophon Therapeutics, Inc. and Martin Dekker (Bellerophon Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Separation Agreement and General Release, dated October 6, 2023, by and between the Company and Kenneth Fisher (Bluejay Diagnostics, Inc., Filed With SEC on November 9, 2023)
- Separation Agreement, dated as of August 25, 2023, between Christina M. Ackermann and Bausch + Lomb Corporation (Bausch & Lomb Corp, Filed With SEC on November 1, 2023)
- Employment Separation Agreement and Release, dated as of October 30, 2003, between Robert Moccia and STRATA Skin Sciences, Inc (STRATA Skin Sciences, Inc., Filed With SEC on October 30, 2023)
- Separation and Shared Services Agreement, between InveniAI LLC and the Registrant, dated November 24, 2021 (Invea Therapeutics, Inc, Filed With SEC on October 20, 2023)
- Separation Agreement, dated as of September 30, 2023, by and between Hyperfine, Inc. and Khan Siddiqui, M.D (HealthCor Catalio Acquisition Corp., Filed With SEC on October 3, 2023)
- Separation and Distribution Agreement, dated as of September 29, 2023, by and between Veralto Corporation and Danaher Corporation (Danaher Corp., Filed With SEC on October 2, 2023)
- Separation Agreement by and between the Registrant and John Dunlop, Ph.D (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
- Separation Agreement, executed as of August 18, 2023, entered into by and between Tandem Diabetes Care, Inc. and Brian Hansen (TANDEM DIABETES CARE INC, Filed With SEC on August 18, 2023)
- Separation Agreement and Release, dated April 1, 2023 by and among Semler Scientific, Inc. and Douglas Murphy-Chutorian (Semler Scientific, Inc., Filed With SEC on August 14, 2023)
- Separation and Release Agreement, dated June 23, 2023, by and between Eargo, Inc. and Christian Gormsen (Eargo, Inc., Filed With SEC on August 10, 2023)
- Separation Agreement and General Release between DH Dental Employment Services LLC and Jean-Claude Kyrillos (Envista Holdings Corp, Filed With SEC on August 2, 2023)
- Separation Agreement, dated June 30, 2023, by and between Niamh Pellegrini and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Transition and Separation Agreement, dated May 23, 2023, by and between the Company and Kevin A. Richardson, II (SANUWAVE Health, Inc., Filed With SEC on May 30, 2023)
- Separation Agreement, dated as of May 4, 2023, by and between Bellerophon Therapeutics, Inc. and Nicholas Laccona (Bellerophon Therapeutics, Inc., Filed With SEC on May 5, 2023)
- Severance and Separation Agreement dated January 10, 2023 by and between Avanos Medical, Inc. and William D. Haydon (Avanos Medical Inc, Filed With SEC on May 3, 2023)
- Separation Agreement, dated as of November 29, 2022, by and between the company and Rick A. Cassiday (Invacare Corporation, Filed With SEC on April 14, 2023)
- Separation Agreement and Release between Kenneth Reali and Bioventus Inc., dated April 4, 2023 (Bioventus Inc., Filed With SEC on April 5, 2023)
- Amended and Restated Separation Agreement dated December 22, 2022 between Bausch + Lomb Corporation and Joseph C. Papa (Bausch & Lomb Corp, Filed With SEC on February 22, 2023)
- Separation Agreement, dated as of February 6, 2023, by and between Hyperfine, Inc. and Neela Paykel (HealthCor Catalio Acquisition Corp., Filed With SEC on February 8, 2023)
- Termination of Employment and Separation Agreement dated January 23, 2023 by and between Dror Bacher and Labstyle Innovation Ltd (DarioHealth Corp., Filed With SEC on January 27, 2023)
- Separation and Release Agreement, dated December 27, 2022, by and between the Company and David Clapper (MINERVA SURGICAL INC, Filed With SEC on December 28, 2022)
- Separation Agreement and Release, dated December 8, 2022, by and between the Company and Ron Price (Accelerate Diagnostics, Inc, Filed With SEC on December 13, 2022)
- Separation Agreement and General Release, entered into December 5, 2022, between Invacare Corporation and Matthew E. Monaghan (Invacare Corporation, Filed With SEC on December 9, 2022)
- Separation Agreement and General Release and Waiver, dated December 2, 2022, between Sanara MedTech Inc. and Shawn M. Bowman (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on December 6, 2022)
